Compile Data Set for Download or QSAR
Report error Found 35 Enz. Inhib. hit(s) with all data for entry = 12735
TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724226(US20250066345, Compound I-18)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724243(US20250066345, Compound I-51)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724241(US20250066345, Compound I-49)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724240(US20250066345, Compound I-48)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724235(US20250066345, Compound I-42)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724234(US20250066345, Compound I-41)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724233(US20250066345, Compound I-40)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724232(US20250066345, Compound I-39)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724231(US20250066345, Compound I-25)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724230(US20250066345, Compound I-24)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724229(US20250066345, Compound I-23)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724209(US20250066345, Compound I-1)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724225(US20250066345, Compound I-17)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724224(US20250066345, Compound I-16)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724215(US20250066345, Compound I-7)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724210(US20250066345, Compound I-2)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724211(US20250066345, Compound I-3)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724212(US20250066345, Compound I-4)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724213(US20250066345, Compound I-5)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724214(US20250066345, Compound I-6)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724216(US20250066345, Compound I-8)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724220(US20250066345, Compound I-12)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724221(US20250066345, Compound I-13)
Affinity DataIC50: 250nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724217(US20250066345, Compound I-9)
Affinity DataIC50: 625nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724219(US20250066345, Compound I-11)
Affinity DataIC50: 625nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724242(US20250066345, Compound I-50)
Affinity DataIC50: 625nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724222(US20250066345, Compound I-14)
Affinity DataIC50: 625nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724218(US20250066345, Compound I-10)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724223(US20250066345, Compound I-15)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724228(US20250066345, Compound I-22)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724227(US20250066345, Compound I-19)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724236(US20250066345, Compound I-43)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724237(US20250066345, Compound I-45)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724238(US20250066345, Compound I-46)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent

TargetPolyunsaturated fatty acid lipoxygenase ALOX12(Human)
Veralox Therapeutics

US Patent
LigandPNGBDBM724239(US20250066345, Compound I-47)
Affinity DataIC50: 1.00E+3nMAssay Description:Reaction buffers used for the lipoxygenase assay were as follows: 25 mM HEPES (pH 7.5), with 0.01% Triton X-100. 1 mM 12-HPETE or 1 mM 15-HPETE stock...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/30/2025
Entry Details
Go to US Patent